Michelle Mendenhall

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Imatinib is not a potent anti-SARS-CoV-2 drug”.

Imatinib is not a potent anti-SARS-CoV-2 drug

Leukemia(2020)10.1038/s41375-020-01045-9

N/A

2.6DataRank · unranked

45 citations

Michelle Mendenhall, Michael W. Deininger, Helong Zhao

In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.18.103184

N/A

0DataRank · unranked

24 citations

Xudong Yuan, Gang Wei, Wei Wang, Ming Zhang, Haizhou Peng +9 more

In vitro effect of a non-immunosuppressive FKBP ligand, FK1706, on SARS-CoV-2 replication in combination with antivirals

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.03.479080

N/A

0DataRank · unranked

3 citations

Tracy L. Hartman, Michelle Mendenhall, Catherine Z. Chen, William E. Fitzsimmons